PT  - JOURNAL ARTICLE
AU  - Cunningham, Muriel
ED  - Hanley, Daniel F.
TI  - Update on the MISTIE Trial
DP  - 2008 May 01
TA  - MD Conference Express
PG  - 10--10
VI  - 8
IP  - 1
4099  - http://mdc.sagepub.com/content/8/1/10.1.short
4100  - http://mdc.sagepub.com/content/8/1/10.1.full
AB  - Intracerebral hemorrhage (ICH) mortality estimates range from 37% (STICH trial) to 56% (SCHIPA trial). The Minimally Invasive Surgery plus t-PA for Intracerebral Hemorrhage Evacuation [MISTIE] trial was a phase 2 study sponsored by the National Institute of Neurological Disease and Stroke. The objective of the study was to determine whether reduction of clot size in ICH leads to lower mortality and better outcomes for patients.